Citation Impact
Citing Papers
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin Use
2002 Standout
Evaluation of aspirin metabolites as inhibitors of hypoxia-inducible factor hydroxylases
2008 StandoutNobel
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
1996 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
1998 Standout
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
New Antithrombotic Drugs
2012
Platelet-Active Drugs
1998
Prognosis and Management after a First Myocardial Infarction
1990
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
1996 Standout
Clinical Implications of Prostaglandin and Thromboxane A2Formation
1988
Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: A critique
1991
Platelet Activation and Atherothrombosis
2007 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
2006 Standout
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
1993 Standout
Antiplatelet Drugs
2008
Risk Factors for Hip Fracture in Men from Southern Europe: The MEDOS Study
1999
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
2004 Standout
Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
2000 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Mineral density quantitation of the human cortical iliac crest by backscattered electron image analysis: Variations with age, sex, and degree of osteoarthritis
1995
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Epidemiology of Hip Fractures
1997
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
1999 Standout
Warfarin, Aspirin, or Both after Myocardial Infarction
2002
Clinical Implications of Prostaglandin and Thromboxane A2Formation
1988
Regulatory Functions of the Vascular Endothelium
1990 StandoutNobel
Prophylactic aspirin and risk of peptic ulcer bleeding
1995
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
2017 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Hemorrhagic Complications of Anticoagulant Treatment
1998
Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults
2003 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
Low-Dose Aspirin Therapy for Chronic Stable Angina
1991
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2004
Platelet-Active Drugs
2001
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
2004
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin
1998
Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
1989
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Inhibition of Endothelial Regeneration by Type-Beta Transforming Growth Factor from Platelets
1986 StandoutScience
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
1994 Standout
Aspirin after myocardial infarction
1989
Review papers : The statistical basis of meta-analysis
1993
The Human Immunodeficiency Virus: Infectivity and Mechanisms of Pathogenesis
1988 StandoutScience
Immunology: Approaches to AIDS therapy
1986 StandoutNatureNobel
The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials.
1993
Aspirin and Other Platelet-Active Drugs
1992
Bronchoscopic diagnosis of pneumonia
1994
Use of Bronchoalveolar Lavage to Diagnose Acute Diffuse Pneumonia in the Immunocompromised Host
1986 StandoutNobel
Hemorrhagic Complications of Long-term Anticoagulant Therapy
1989
Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty
1987
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Hemorrhagic Complications of Anticoagulant Treatment
1992
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Blood pressure, stroke, and coronary heart disease
1990 Standout
Hemorrhagic Complications of Long-term Anticoagulant Therapy
1986
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable Angina
1983
Clinical Aspects of Platelet Inhibitors and Thrombus Formation
2007
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Coronary Plaque Disruption
1995 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
The Acquired Immunodeficiency Syndrome: An Update
1985
Hemorrhagic Complications of Anticoagulant Treatment
1995
Biochemical and mechanical properties of subchondral bone in osteoarthritis.
2004
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis
1996 StandoutNobel
Secondary prevention after myocardial infarction: A review of long-term trials
1982
Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.
1989
The randomized clinical trial: bias in analysis.
1981
Aortic stenosis, angina, and coronary artery disease. Interrelations.
1975
Meta-analysis in clinical trials
1986 Standout
Vessel injury, platelet adherence, and platelet survival.
1983
Works of D Loew being referenced
The diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome using subsegmental bronchoalveolar lavage.
1984
[Use of acetylsalicylic acid in the prevention of re-occlusion following revascularization interventions. Results of a double-blind long term study].
1977
Osteoarthritis protects against femoral neck fracture: The MEDOS study experience
1993
Secondary Prevention of Myocardial Infarction: a Comparison of Acetylsalicylic Acid, Placebo and Phenprocoumon
1980
Secondary Prevention of Myocardial Infarction Comparison of Acetylsalicylic Acid, Phenprocoumon and Placebo
1979
Dose-Dependent Influence of Acetylsalicylic Acid on Platelet Functions and Plasmatic Coagulation Factors
1976
Valvular heart disease: Undiagnosed valvular involvement, concomitant coronary artery disease and systemic embolization
1972